-
1
-
-
84871051576
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
-
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2163-2196.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2163-2196
-
-
Vos, T.1
Flaxman, A.D.2
Naghavi, M.3
-
2
-
-
79952449206
-
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication
-
McClintock SM, Husain MM, Wisniewski SR, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011; 31(2): 180-186.
-
(2011)
J Clin Psychopharmacol
, vol.31
, Issue.2
, pp. 180-186
-
-
McClintock, S.M.1
Husain, M.M.2
Wisniewski, S.R.3
-
3
-
-
33751338530
-
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR,D report
-
Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR,D report. Am J Psychiatry.2006; 163(11): 1905-1917.
-
(2006)
Am J Psychiatry
, vol.163
, Issue.11
, pp. 1905-1917
-
-
Rush, A.J.1
Trivedi, M.H.2
Wisniewski, S.R.3
-
4
-
-
37349044684
-
The STAR,D Project results: A comprehensive review of findings
-
Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR,D Project results: A comprehensive review of findings. Curr Psychiatry Rep. 2007; 9(6): 449-459.
-
(2007)
Curr Psychiatry Rep
, vol.9
, Issue.6
, pp. 449-459
-
-
Warden, D.1
Rush, A.J.2
Trivedi, M.H.3
Fava, M.4
Wisniewski, S.R.5
-
5
-
-
33745399074
-
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression
-
Dunner DL, Rush AJ, Russell JM, et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry. 2006; 67(5): 688-695.
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.5
, pp. 688-695
-
-
Dunner, D.L.1
Rush, A.J.2
Russell, J.M.3
-
6
-
-
84872663272
-
Evidence-based treatment strategies for treatment-resistant bipolar depression: A systematic review
-
Sienaert P, Lambrichts L, Dols A, De Fruyt J. Evidence-based treatment strategies for treatment-resistant bipolar depression: A systematic review. Bipolar Disord. 2013; 15(1): 61-69.
-
(2013)
Bipolar Disord.
, vol.15
, Issue.1
, pp. 61-69
-
-
Sienaert, P.1
Lambrichts, L.2
Dols, A.3
De Fruyt, J.4
-
7
-
-
77955302215
-
The pharmacologic treatment of anxiety disorders: A review of progress
-
Ravindran LN, Stein MB. The pharmacologic treatment of anxiety disorders: A review of progress. J Clin Psychiatry. 2010; 71(7): 839-854.
-
(2010)
J Clin Psychiatry
, vol.71
, Issue.7
, pp. 839-854
-
-
Ravindran, L.N.1
Stein, M.B.2
-
8
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12): 1209-1223.
-
(2005)
N Engl J Med
, vol.353
, Issue.12
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
-
9
-
-
84907278618
-
Treatment resistant schizophrenia: A comprehensive survey of randomised controlled trials
-
Sinclair D, Adams CE. Treatment resistant schizophrenia: A comprehensive survey of randomised controlled trials. BMC Psychatry. 2014; 14: 253.
-
(2014)
BMC Psychatry
, vol.14
, pp. 253
-
-
Sinclair, D.1
Adams, C.E.2
-
10
-
-
40549089935
-
Influence of the CYP2D6,4 polymorphism on dose, switching and discontinuation of antidepressants
-
Bijl MJ, Visser LE, Hofman A, et al. Influence of the CYP2D6,4 polymorphism on dose, switching and discontinuation of antidepressants. Br J Clin Pharmacol. 2008; 65(4): 558-564.
-
(2008)
Br J Clin Pharmacol
, vol.65
, Issue.4
, pp. 558-564
-
-
Bijl, M.J.1
Visser, L.E.2
Hofman, A.3
-
11
-
-
77951844279
-
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
-
Kato M, Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry. 2010; 15(5): 473-500.
-
(2010)
Mol Psychiatry
, vol.15
, Issue.5
, pp. 473-500
-
-
Kato, M.1
Serretti, A.2
-
12
-
-
84856209453
-
Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: A replication study
-
Risselada AJ, Vehof J, Bruggeman R, et al. Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: A replication study. Pharmacogenomics J. 2012; 12(1): 62-67.
-
(2012)
Pharmacogenomics J
, vol.12
, Issue.1
, pp. 62-67
-
-
Risselada, A.J.1
Vehof, J.2
Bruggeman, R.3
-
13
-
-
84898047653
-
Pharmacogenomic testing for neuropsychiatric drugs: Current status of drug labeling, guidelines for using genetic information, and test options
-
Drozda K, Müller DJ, Bishop J.R. Pharmacogenomic testing for neuropsychiatric drugs: Current status of drug labeling, guidelines for using genetic information, and test options. Pharmacotherapy. 2014; 34(2): 166-184.
-
(2014)
Pharmacotherapy
, vol.34
, Issue.2
, pp. 166-184
-
-
Drozda, K.1
Müller, D.J.2
Bishop, J.R.3
-
14
-
-
84876665512
-
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants
-
Hicks JK, Swen JJ, Thorn CF, et al. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther.2013; 93(5): 402-408.
-
(2013)
Clin Pharmacol Ther
, vol.93
, Issue.5
, pp. 402-408
-
-
Hicks, J.K.1
Swen, J.J.2
Thorn, C.F.3
-
15
-
-
79955463893
-
Pharmacogenetics: From bench to byte-an update of guidelines
-
Swen JJ, Nijenhuis M, de Boer A, et al. Pharmacogenetics: From bench to byte-an update of guidelines. Clin Pharmacol Ther.2011; 89(5): 662-673.
-
(2011)
Clin Pharmacol Ther
, vol.89
, Issue.5
, pp. 662-673
-
-
Swen, J.J.1
Nijenhuis, M.2
De Boer, A.3
-
16
-
-
38149003759
-
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression
-
Uhr M, Tontsch A, Namendorf C, et al. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron.2008; 57(2): 203-209.
-
(2008)
Neuron
, vol.57
, Issue.2
, pp. 203-209
-
-
Uhr, M.1
Tontsch, A.2
Namendorf, C.3
-
17
-
-
84931335155
-
Análisis Farmacogenético en psiquiatriá estudio descriptivo de una experiencia clínica con 21 pacientes
-
Vega M, Sánchez P, Garciá M, et al. Análisis Farmacogenético en psiquiatriá, estudio descriptivo de una experiencia clínica con 21 pacientes. Psiquiatria.com. 2012; 16: 5.
-
(2012)
Psiquiatria.com
, vol.16
, pp. 5
-
-
Vega, M.1
Sánchez, P.2
Garciá, M.3
-
18
-
-
84881377249
-
Medication nonadherence and psychiatry
-
Chapman SCE, Horne R. Medication nonadherence and psychiatry. Curr Opin Psychiatry. 2013; 26(5): 446-452.
-
(2013)
Curr Opin Psychiatry
, vol.26
, Issue.5
, pp. 446-452
-
-
Chapman, S.C.E.1
Horne, R.2
-
19
-
-
84901255199
-
Providing patients with pharmacogenetic test results affects adherence to statin therapy: Results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial
-
Charland SL, Agatep BC, Herrera V, et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy: Results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. Pharmacogenomics J.2014; 14(3): 272-280.
-
(2014)
Pharmacogenomics J.
, vol.14
, Issue.3
, pp. 272-280
-
-
Charland, S.L.1
Agatep, B.C.2
Herrera, V.3
-
20
-
-
84889610517
-
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder
-
Winner J, Carhart JM, Altar CA, Allen JD, Dechairo BM. A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder. Discov Med. 2013; 16(89): 219-227.
-
(2013)
Discov Med
, vol.16
, Issue.89
, pp. 219-227
-
-
Winner, J.1
Carhart, J.M.2
Altar, C.A.3
Allen, J.D.4
Dechairo, B.M.5
-
21
-
-
84885082776
-
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting
-
Hall-Flavin DK, Winner JG, Allen JD, et al. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenet Genomics. 2013; 23(10): 535-548.
-
(2013)
Pharmacogenet Genomics
, vol.23
, Issue.10
, pp. 535-548
-
-
Hall-Flavin, D.K.1
Winner, J.G.2
Allen, J.D.3
-
22
-
-
84880452154
-
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
-
Winner J, Allen JD, Anthony Altar C, Spahic-Mihajlovic A. Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression. Transl Psychiatry. 2013; 3: E242.
-
(2013)
Transl Psychiatry
, vol.3
, pp. E242
-
-
Winner, J.1
Allen, J.D.2
Anthony Altar, C.3
Spahic-Mihajlovic, A.4
-
23
-
-
84883746349
-
Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costs
-
Herbild L, Andersen SE, Werge T, Rasmussen HB, Jürgens G. Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costsBasic Clin Pharmacol Toxicol. 2013; 113(4): 266-272.
-
(2013)
Basic Clin Pharmacol Toxicol
, vol.113
, Issue.4
, pp. 266-272
-
-
Herbild, L.1
Andersen, S.E.2
Werge, T.3
Rasmussen, H.B.4
Jürgens, G.5
-
24
-
-
84901707207
-
The clinical application of ABCB1 genotyping in antidepressant treatment: A pilot study
-
Breitenstein B, Scheuer S, Pfister H, et al. The clinical application of ABCB1 genotyping in antidepressant treatment: A pilot study. CNS Spectr.2014; 19(2): 165-175.
-
(2014)
CNS Spectr
, vol.19
, Issue.2
, pp. 165-175
-
-
Breitenstein, B.1
Scheuer, S.2
Pfister, H.3
|